BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6975508)

  • 1. Immune response of regional lymph nodes in patients with lung cancer.
    Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
    Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of T gamma cells in the regional lymph nodes of patients with uterine cervical cancer].
    Hiramatsu K; Ueda G; Inoue M; Tanaka Y; Inoue Y; Saito J; Nishino T; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):947-52. PubMed ID: 6223965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial carcinoma and its regional lymph nodes in relation to immunological functions.
    Syrjänen KJ
    Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):212-22. PubMed ID: 311556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on immune response of regional lymph nodes in patients with lung cancer].
    Sannoh K
    Igaku Kenkyu; 1984 May; 54(6):695-709. PubMed ID: 6532067
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphatic mast cells in response to in vitro stimulation by non-specific T-cell mitogens.
    Włodarski K; Rychlik G; Mazur S
    Immunology; 1985 Jun; 55(2):311-5. PubMed ID: 3874150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastogenic response of swine lymphocytes in whole blood, purified blood, spleen cell, and lymph node cell cultures with concanavalin A and phytohemagglutinin.
    Hussain A; Tripathy RN; Mohanty SB; Rockemann DD
    Am J Vet Res; 1981 May; 42(5):873-5. PubMed ID: 7258810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation of mitogenic response in foetal guinea-pig.
    Merikanto J
    Immunology; 1979 Dec; 38(4):677-86. PubMed ID: 316415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
    Kadoyama C; Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomorphologic responses of regional lymph nodes and prognosis in patients with stage Ia pulmonary adenocarcinoma].
    Takakura H; Hirohasi S; Shimosato Y; Kodama T; Kameya T; Naruke T; Suemasu K
    Gan No Rinsho; 1983 Jun; 29(7):777-84. PubMed ID: 6876444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS; Bowker RJ; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1529-33. PubMed ID: 2949828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.